Hear why Merck KGaA and INBRAIN Neurolectronics see such great promise in Bioelectronic medicine

Hear why Merck KGaA and INBRAIN Neurolectronics see such great promise in Bioelectronic medicine
DeviceTalks Podcast Network
Hear why Merck KGaA and INBRAIN Neurolectronics see such great promise in Bioelectronic medicine

Jul 23 2021 | 00:42:16

/
Episode • July 23, 2021 • 00:42:16

Hosted By

Kayleen Brown Tom Salemi

Show Notes

The bioelectronics industry is poised to take off so we visited with Carolina Aguilar, CEO/Co-founder, INBRAIN Neuroelectronics about the field's potential. Chris Newmarker, executive editor of life sciences at MassDevice, delivers his Newmarker's Newsmakers highlighting news from Dexcom, NeuroMetrix, Nevro, Ancora and the Galien foundation. Subscribe to this podcast on Google, Amazon, Apple, Spotify and other major podcast channels.

Previous Episode

Hear from the CEOs of two surgical robotics companies that together just raised over $1 billion

Next Episode

What's next in Diabetes? CeQur moving toward manufacturing, Medtronic readying for the long haul

Other Episodes

August 25, 2023

CEO McCutcheon leaning on lessons from past successes, disappointments to move EBR Systems forward

In this week’s podcast, we’ll visit with John McCutcheon, president and CEO of EBR Systems, which is developing a miniature pacemaker that is powered...

Play

00:43:01

July 17, 2024

Stryker’s Pierce updates on Vocera, 1788, Neuro, & interest in soft-tissue surgical robotics system

In this episode of StrykerTalks, we welcome back Andy Pierce, Group President of MedSurg and Neurotechnology, to discuss the impact of the Vocera acquisition...

Play

00:33:14

April 19, 2023

Boston Scientific's Drew Bomett discusses challenges of cybersecurity protection for medical devices

How concerned should you be about cybersecurity? And as an industry, how do we reduce the risk of using medical devices and potentially exposing...

Play

00:38:04